PASITHEA THERAPEUTICS CORP. Accounts Payable and Accrued Liabilities, Current
PASITHEA THERAPEUTICS CORP. (KTTA) had Accounts Payable and Accrued Liabilities, Current of $1.84 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable and Accrued Liabilities, Current $1.84M.
- 2026-03-31: Accounts Payable and Accrued Liabilities, Current $1.49M.
- 2025-12-31: Accounts Payable and Accrued Liabilities, Current $1.13M.
- 2025-09-30: Accounts Payable and Accrued Liabilities, Current $1.34M.
| Period end | Accounts Payable and Accrued Liabilities, Current | Accounts Payable and Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.84M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.49M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $1.13M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $1.34M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.58M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.33M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.12M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $660.40K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.39M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $2.43M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $2.55M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $1.87M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.93M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $1.45M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.48M 10-K · filed 2024-03-29 | $1.61M 10-K · filed 2023-03-30 |
| 2022-09-30 | $1.26M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $848.69K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $433.68K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $447.28K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $528.10K 10-Q · filed 2021-11-18 | |
| 2020-12-31 | $6.60K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |